Below are the financial statements of Sartorius Stedim Biotech, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of EUR | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Non-current assets | — | — |
| Goodwill | 2,907.9a | 2,885a |
| Other intangible assets | 1,631.7a | 1,693.3a |
| Property, plant and equipment | 1,885.2a | 1,633.2a |
| Financial assets | 24a | 40.8a |
| Other assets | 3.3a | 2.6a |
| Deferred tax assets | 63.2a | 60a |
| Non-current assets | 6,515.4a | 6,314.9a |
| Current assets | — | — |
| Inventories | 684.9a | 882.4a |
| Trade receivables | 265.9a | 293.7a |
| Other financial assets | 11.7a | 16.5a |
| Current tax assets | 33.8a | 39.8a |
| Other assets | 65.8a | 66.1a |
| Cash and cash equivalents | 678.9a | 116.6a |
| Current assets | 1,741a | 1,415.1a |
| Total assets | 8,256.4a | 7,730.1a |
| Equity | — | — |
| Equity attributable to SSB S.A. shareholders | 3,986.6a | 2,638.5a |
| Issued capital | 19.5a | 18.4a |
| Capital reserves | 1,424.1a | 231.5a |
| Retained earnings (including net profit) | 2,543.1a | 2,388.5a |
| Non-controlling interest | 37.2a | 35.3a |
| Equity | 4,023.8a | 2,673.8a |
| Non-current liabilities | — | — |
| Pension provisions | 33.6a | 30.3a |
| Other provisions | 15.1a | 13.8a |
| Loans and borrowings | 2,684.4a | 3,509.7a |
| Lease liabilities | 120.6a | 93.1a |
| Other financial liabilities | 81.9a | 82.7a |
| Deferred tax liabilities | 358.2a | 389.4a |
| Non-current liabilities | 3,293.8a | 4,119a |
| Current liabilities | — | — |
| Provisions | 17.4a | 14.1a |
| Trade payables | 310a | 258.5a |
| Contract liabilities | 216.1a | 238.6a |
| Loans and borrowings | 39.5a | 57.7a |
| Lease liabilities | 25a | 21.4a |
| Other financial liabilities | 71.9a | 44.8a |
| Employee benefits | 88.2a | 62.3a |
| Current tax liabilities | 123.2a | 189.4a |
| Other liabilities | 47.6a | 50.5a |
| Current liabilities | 938.8a | 937.3a |
| Total equity and liabilities | 8,256.4a | 7,730.1a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sartorius Stedim Biotech’s data sources below and access millions more through our Disclosure Search.